Latest News

Cancer drugs block dementia-linked brain inflammation, study finds

A class of drugs developed to treat immune-related conditions and cancer -- including one currently in clinical trials for glioblastoma and other tumors -- eliminates neural inflammation associated with dementia-linked diseases and brain injuries, according to researchers. In their study, the researchers discovered that the drugs, which can be delivered orally, eradicated microglia, the primary immune cells of the brain. These cells exacerbate many neural diseases, including Alzheimer's and Parkinson's, as well as brain injury.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Clot dissolver tpa's tardy twin could aid in stroke recovery

  • If you're over 60, drink up: Alcohol associated with better memory

  • New window of opportunity to prevent cardiovascular, diseases

  • Genes exhibit different behaviours in different stages of development

  • Human skin cells reprogrammed directly into brain cells

  • Bipolar disorder discovery at the nano level

  • Smoking interferes with neurocognitive recovery during abstinence from alcohol

  • Stress-related inflammation may increase risk for depression

  • Biochemical cause of seasonal depression (SAD) confirmed by researchers

  • Key factor in transition from moderate to problem drinking

  •